Markets
GSK plc (GSK)
GSKNYSEBiotechnology: Pharmaceutical Preparations
$51.36
-0.1800 (-0.35%) today
Regular session, Nov 10, 2:25 PM ET
-0.33% 1D
- Market cap
- $103.91bn
- P/E
- 10.8
- EPS, last 4 quarters
- $4.75
- Dividend yield
- –
- Day range
- $51.01 to $51.89
- 52-week range
- $45.81 to $61.70
- Average volume
- –
- Previous close
- $51.54
Analysts
1 coveringHold0 buy, 1 hold, 0 sell
Targets a year out average $57.95, +12.8% from here
$55.90now $51.36$60.00
Earnings
next estimate $0.7700Next report
Dec 2025
+6.3%
Mar 2026
+6.0%
Jun 2026
+7.1%
Sep 2026
+5.0%
estimate reported, and the surprise
Financials
No quarterly figures from the source.
News
8 latest- Buy Moderna Stock Before Q3 Earnings? Here's What to KnowZacks · Nov 2, 2026
- GSK vs. Moderna: Which Large-Cap Biotech Stock Offers More Growth?Zacks · Oct 29, 2026
- Biotech Stocks Facing FDA Decision In November 2026 RTTNews · Oct 29, 2026
- GSK (GSK) Q3 2026 Earnings Call TranscriptThe Motley Fool · Oct 28, 2026
- What GSK (GSK) Said on Its Q3 Earnings CallMarketBeat · Oct 28, 2026
- GSK Q3 Earnings Top Mark, Stock Down on Soft Vaccines SalesZacks · Oct 28, 2026
- GSK (GSK) Q3 Earnings and Revenues Beat EstimatesZacks · Oct 28, 2026
- GSK Q3 Core Operating Profit Rises; Reaffirms 2026 Guidance RTTNews · Oct 28, 2026
The company
GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NYSE
- Region
- Europe
- Website
- gsk.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.